Synthesis of acridinium compounds by N-alkylation of acridans

Patent metadata

Field	Value
Publication number	US-9512080-B2
Application number	US-201314414081-A
Country	US
Kind code	B2
Filing date	Jul 10, 2013
Priority date	Jul 10, 2012
Publication date	Dec 6, 2016
Grant date	Dec 6, 2016

Abstract

A method is provided for N-alkylation of acridine compounds by reduction of acridines to corresponding acridans to improve the reactivity of the acridine nitrogen, and subsequent N-alkylation of the acridans in ionic liquid solvents to provide the corresponding acridinium compounds in high yield. This inventive process improves chemical conversion, and does not require the use of highly toxic alkylating agents, such as 1,3-propane sultone.

First claim

We claim:

1. A method for N-alkylation of an acridine compound, the method comprising:
(a) reacting said acridine compound with a reducing agent to thereby convert said acridine compound to an acridan compound;
(b) reacting said acridan compound with an alkylating agent in an ionic liquid solvent to thereby convert said acridan compound to an N-alkylacridan; and
(c) oxidizing said N-alkylacridan to thereby convert said N-alkylacridan to an N-alkyl acridinium compound.

2. The method according to claim 1 , wherein said alkylating agent is a sulfonate.

3. The method according to claim 2 , wherein said sulfonate has the structure:

where n is an integer from 1 to 20,
L is a halogen or —OR L , wherein R L is an acetyl or a sulfonyl group, optionally substituted with one or more linear, branched or cyclic alkyl groups, wherein said alkyl groups optionally comprise one or more heteroatoms and optionally include one or more unsaturated bonds, and
A is a counterion.

4. The method according to claim 3 , wherein n is an integer from 1 to 10.

5. The method according to claim 4 , wherein n is an integer from 1 to 5.

6. The method according to claim 3 , wherein L′ is chloride, bromide, or —OR L , where R L is selected from the group consisting of acetyl, methanesulfonyl, or p-toluenesulfonyl groups.

7. The method according to claim 3 , wherein A is a sodium or potassium cation.

8. The method according to claim 2 , wherein said alkylating agent is sodium 3-bromopropanesulfonate.

9. The method according to claim 1 , wherein said reducing agent is a metal hydride.

10. The method according to claim 1 , wherein said reducing agent is a borane complex of an amine or a cyanoborohydride complex comprising an alkali metal cation.

11. The method according to claim 10 , wherein said reducing agent is selected from the group consisting of sodium borohydride, lithium borohydride, potassium borohydride, sodium cyanoborohydride, potassium cyanoborohydride, or picoline-borane.

12. The method according to claim 11 , wherein said reducing agent is sodium cyanoborohydride or picoline-borane.

13. The method according to claim 1 , wherein said reducing agent is a catalyst for catalytic hydrogenation.

14. The method according to claim 13 , wherein said reducing agent comprises platinum or palladium.

15. The method according to claim 1 , wherein said ionic liquid solvent is of the form:

where n is an integer from one to nine; and Y is selected from the group consisting of tetrachloroaluminate; hexafluroantimonate; dicyanamide; thiocyanate; nitrate; chloride; iodide; trifluoroacetate; tetrafluoroborate; hexafluorophosphate; methylsulfonate; trifluoromethylsulfonate; tris(pentafluoroethyl)trifluorophosphate; bis(trifluoroinethylsulfonyl)imide, and combinations thereof.

16. The method according to claim 15 , wherein the ionic solvent comprises [BMIM][PF 6 ] (1-butyl-3-methylimidazolium hexafluorophosphate).

17. The method according to claim 15 , wherein the ionic solvent comprises [BMIM][BF 4 ] (1-butyl-3-methylimidazolium tetrafluoroborate).

18. The method according to claim 1 , wherein step (b) is reacted in the presence of a base, wherein said base is unreactive with said alkylating agent under the reaction conditions.

19. The method according to claim 18 , wherein said base is selected from the group consisting of potassium carbonate, sodium carbonate, and cesium carbonate.

20. The method according to claim 18 , wherein said base is a sterically hindered pyridine derivative.

21. The method according to claim 20 , wherein said base comprises 2,6-di-t-butylpyridine (DtBP) or 2,6-di-t-butyl-4-methylpyridine (DtBMP), or a combination thereof.

22. The method according to claim 1 , wherein said acridine compound is an acridine ester.

23. The method according to claim 1 , wherein said acridine compound is an acridine sulfonamide.

24. A method for preparing an acridinium ester compound having the structure of formula (V):

wherein R 7 and R 8 can be the same or different, and are selected from the group consisting of hydrogen, halogen, —OR, and R; where R is an alkyl, alkenyl, alkynyl, aryl, or aralkyl group containing up to 20 heteroatoms selected from oxygen, sulfur, and nitrogen; wherein R 10 and R 11 can be the same or different and represent hydrogen, an alkyl, alkenyl, alkynyl, aryl, or aralkyl group containing up to 20 heteroatoms; and wherein R.sub.12 is —OR; the method comprising: (a) reacting an acridine compound having the structure of formula (Vb)

wherein R 7 , R 8 , R 10 , R 11 and R 12 are as defined above, with a reducing agent to thereby convert said acridine compound to an acridan compound having the structure of formula (Vd):

wherein R 7 , R 8 , R 10 , R 11 and R 12 are as defined above; (b) reacting said acridan compound with an alkylating agent in an ionic liquid solvent to thereby convert said acridan compound to an N-alkylacridan having the structure of formula (Ve):

wherein R 7 , R 8 , R 10 , R 11 and R 12 are as defined above; and (c) oxidizing said N-alkylacridan to thereby convert said N-alkylacridan to said acridinium ester.

25. A method for preparing an acridinium sulfonamide compound having the structure of formula (VI):

wherein R 7 and R 8 can be the same or different, and are selected from the group consisting of hydrogen, halogen, —OR, and R; where ft is an alkyl, alkenyl, alkynyl, aryl, or aralkyl group containing up to 20 heteroatoms selected from oxygen, sulfur, and nitrogen; and wherein R 13 and R 14 can be the same or different and represent an alkyl, alkenyl, alkynyl, aryl, or aralkyl group containing up to 20 heteroatoms; the method comprising: (a) reacting an acridine compound having the structure of formula (VIa)

wherein R 7 , R 8 , R 13 and R 14 are as defined above, with a reducing agent to thereby convert said acridine compound to an acridan compound having the structure of formula (VIb):

wherein R 7 , R 8 , R 13 and R 14 are as defined above; (b) reacting said acridan compound with an alkylating agent in an ionic liquid solvent to thereby convert said acridan compound to an N-alkylacridan having the structure of formula (VIc):

wherein R 7 , R 8 , R 13 and R 14 are as defined above; and (c) oxidizing said N-alkylacridan to thereby convert said N-alkylacridan to said acridinium ester.

26. A met

Assignees

• Siemens Healthcare Diagnostics Inc

Inventors

• Natrajan Anand
• Wen David

Classifications

• C07D219/04 Primary

  with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system · CPC title